FNY Managed Accounts’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q1	$0	Hold	127	–	–	﹤0.01%	978
2017 Q4	$1K	Sell	127 -1,957	-94%	-$15.4K	﹤0.01%	569
2017 Q3	$23K	Buy	+2,084	New	+$23K	0.03%	304
2016 Q2	–	Sell	-1,271	Closed	-$83.7K	–	402
2016 Q1	$83.7K	Buy	+1,271	New	+$83.7K	0.15%	104